Park H. An overview of eosinophilic esophagitis. Gut Liver. 2014;8:590-597.
Dellon ES, Muir AB, Katzka DA, et al. ACG clinical guideline: diagnosis and management of eosinophilic esophagitis. Am J Gastroenterol. 2025;120:31-59.
Thel HL, Anderson C, Xue AZ, Jensen ET, Dellon ES. Prevalence and costs of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol. 2025;23:272-280.e8.
Chehade M, Wright BL, Walsh S, et al. Challenging assumptions about the demographics of eosinophilic gastrointestinal diseases: a systematic review. J Allergy Clin Immunol: Global. 2024:3.
Mansoor E, Cooper GS. The 2010–2015 prevalence of eosinophilic esophagitis in the United States: a population-based study. Dig Dis Sci. 2016;61:2928-2934.
Alexander ES, Martin LJ, Collins MH, et al. Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin Immunol. 2014;134:1084-1092.e1.
Chang JW, Jensen ET. Epidemiologic and clinical clues to the etiology of eosinophilic esophagitis. Immunol Allergy Clin North Am. 2024;44:145-155.
Ogulur I, Mitamura Y, Yazici D, et al. Type 2 immunity in allergic diseases. Cell Mol Immunol. 2025;22:211-242.
Barchi A, Mandarino FV, Yacoub MR, et al. From pathogenesis to treatment: targeting type-2 inflammation in eosinophilic esophagitis. Biomolecules. 2024;14:1080.
Hill DA, Spergel JM. The atopic march: critical evidence and clinical relevance. Ann Allergy Asthma Immunol. 2018;120:131-137.
Banks EC, Ng YC. Essentials of eosinophilic esophagitis: a guide for primary care. J Nurse Pract. 2025;21:105343.
Bredenoord AJ, Patel K, Schoepfer AM, et al. Disease burden and unmet need in eosinophilic esophagitis. Am J Gastroenterol. 2022;117:1231-1241.
Maspero J, Adir Y, Al-Ahmad M, et al. Type 2 inflammation in asthma and other airway diseases. ERJ Open Res. 2022;8:00576-02021.
Chehade M, Falk GW, Aceves S, et al. Examining the role of type 2 inflammation in eosinophilic esophagitis. Gastro Hep Adv. 2022;1:720-732.
Visaggi P, Ghisa M, Vespa E, et al. Optimal assessment, treatment, and monitoring of adults with eosinophilic esophagitis: strategies to improve outcomes. Immunotargets Ther. 2024;13:367-383.
Horwitz A, Yunus S. Eosinophilic esophagitis: a review for the primary care practitioner. Med Clin North Am. 2024;108:733-745.
Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference. Gastroenterology. 2018;155:1022-1033.e10.
- Dellon ES. Eosinophilic esophagitis: tips for the primary care provider. Eosinophilic Esophagitis. Published online 2025. https://practicalgastro.com/wp-content/uploads/2025/05/GUILD-May-2025.pdf
Aceves SS, Alexander JA, Baron TH, et al. Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference. Gastrointest Endosc. 2022;96:576-592.e1.
Schoepfer AM, Safroneeva E, Bussmann C, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 2013;145:1230-1236.e2.
Chehade M, Hiremath GS, Zevit N, et al. Disease burden and spectrum of symptoms that impact quality of life in pediatric patients with eosinophilic esophagitis. Gastro Hep Advances. 2024;3:1054-1068.
Shaheen NJ, Mukkada V, Eichinger CS, Schofield H, Todorova L, Falk GW. Natural history of eosinophilic esophagitis: a systematic review of epidemiology and disease course. Dis Esophagus. 2018;31:doy015.
Chehade M, Wright BL, Atkins D, et al. Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting. J Allergy Clin Immunol. 2023;152:1382-1393.
de Bortoli N, Visaggi P, Penagini R, et al. The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–current treatment and monitoring. Dig Liver Dis. 2024;56:1173-1184.
Kliewer KL, Abonia JP, Aceves SS, et al. One-food versus 4-food elimination diet for pediatric eosinophilic esophagitis: a multisite randomized trial. J Allergy Clin Immunol. 2025;155:520-532.
Kliewer KL, Gonsalves N, Dellon ES, et al. One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial. Lancet Gastroenterol Hepatol. 2023;8:408-421.
Czepiel J, Dróżdż M, Pituch H, et al. Clostridium difficile infection: review. Eur J Clin Microbiol Infect Dis. 2019;38:1211-1221.
Eohilia [package insert]. Lexington, MA: Takeda Pharmaceuticals America, Inc.; May 2024. Accessed 10/29/25 at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213976s001lbl.pdf
Dupixent® [package insert]. Tarrytown, NY: Regeneron Pharmaceuticals, Inc.; June 2025. Accessed 10/29/25 at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761055s070lbl.pdf
de Rooij WE, Bennebroek E, vertsz’ F, Lei A, Bredenoord AJ. Mental distress among adult patients with eosinophilic esophagitis. Neurogastroenterol Motil. 2021;33:e14069.